Sources | Names Used |
---|---|
CTRPv2 | BRD-K24690302 |
PharmacoGx | BRD-K24690302 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CSGALNACT2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | ING2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | CNN2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | AK6 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | CXorf51A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | SLC19A2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | HES5 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | LINGO1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | IRF9 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | TPT1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |